Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
Original language | English |
---|---|
Pages (from-to) | 74-77 |
Journal | Journal of Spinal Disorders and Techniques |
Volume | 23 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Feb 2010 |